A nationwide cohort study of the association of benzodiazepines with SARS-CoV-2 infection and clinical outcomes

The evidence for the impact of benzodiazepine (BZD) use on infection or clinical outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is limited. We evaluated the association of BZD use with SARS-CoV-2 infection and the clinical outcomes of coronavirus disease 2019 (COVID-19) usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hye Yoon, Kwon, Junhyun, An, Suk Kyoon, Park, Eun-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509375/
https://www.ncbi.nlm.nih.gov/pubmed/36153398
http://dx.doi.org/10.1038/s41598-022-20335-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509375/
https://www.ncbi.nlm.nih.gov/pubmed/36153398
http://dx.doi.org/10.1038/s41598-022-20335-z

Ejemplares similares